carboplatin,etoposide,atezolizumab,tiragolumab
roche
['skyscraper-02']
discussant c belani. what went wrong in skyscraper-02? ph3 trial "based on preclinical rationale" #asco22 
Journalist at Evaluate Vantage. Proudly blocked by @JohnCendpts. Interested in: oncology, immunology. Not interested in: what stock you bought today.